Literature DB >> 20725009

FDA challenges stem-cell clinic.

David Cyranoski.   

Abstract

Mesh：

Year:  2010        PMID： 20725009     DOI： 10.1038/466909a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  Stem-cell therapy takes off in Texas.

Authors:  David Cyranoski
Journal:  Nature       Date:  2012-02-29       Impact factor: 49.962

2.  Recent developments in health care law: culture and controversy.

Authors:  Roberta M Berry; Lisa Bliss; Sylvia Caley; Paul A Lombardo; Leslie E Wolf
Journal:  HEC Forum       Date:  2013-03

3.  Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC Products.

Authors:  Guido Moll; James A Ankrum; Scott D Olson; Jan A Nolta
Journal:  Stem Cells Transl Med       Date:  2022-03-03       Impact factor: 7.655

4.  Call for fellowship programs in stem cell-based regenerative and cellular medicine: new stem cell training is essential for physicians.

Authors:  Paul S Knoepfler
Journal:  Regen Med       Date:  2013-03       Impact factor: 3.806

Review 5.  The commercialization of university-based research: Balancing risks and benefits.

Authors:  Timothy Caulfield; Ubaka Ogbogu
Journal:  BMC Med Ethics       Date:  2015-10-14       Impact factor: 2.652

6.  The pluralization of the international: Resistance and alter-standardization in regenerative stem cell medicine.

Authors:  Achim Rosemann; Nattaka Chaisinthop
Journal:  Soc Stud Sci       Date:  2016-02       Impact factor: 3.885

Review 7.  Opportunities and barriers to establishing a cell therapy programme in South Africa.

Authors:  Carlo Stephan Jackson; Michael S Pepper
Journal:  Stem Cell Res Ther       Date:  2013-05-29       Impact factor: 6.832
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.